Effects of the administration of epsilon amino caproic acid on catecholamine and serotonin levels in the rat and dog.
D000311:Adrenal Glands / Q000378:metabolism; D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D001949:Bretylium Compounds / Q000494:pharmacology; D002415:Cats; D004285:Dogs; D006145:Guanethidine / Q000494:pharmacology; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D011874:Radiometry; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D014316:Tritium
D000614:Aminocaproates; D001949:Bretylium Compounds; D014316:Tritium; D012701:Serotonin; D012110:Reserpine; D007490:Iproniazid; D009638:Norepinephrine; D006145:Guanethidine